Investigation on the Interaction of Newly Designed Anticancer Pd(II) Complexes with Different Aliphatic Tails and Human Serum Albumin
- 24 September 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 113 (42) , 14035-14042
Abstract
The pharmacokinetics and pharmacodynamics of any drug will depend, largely, on the interaction that it has with human serum albumin (HSA), the most abundant plasma protein. The interaction between newly synthesized Pd(II) complexes, 2,2′-bipyridin octyl dithiocarbamato Pd(II) nitrate (Octpd), 2,2′-bipyridin butyl dithiocarbamato Pd(II) nitrate (ButPd), 2,2′-bipyridin ethyl dithiocarbamato Pd(II) nitrate (EtPd), antitumor components, with human serum albumin, a carrier protein, were studied at different temperatures of 27 and 37 °C by fluorescence spectroscopy, far UV circular dichroism (CD), and spectrophotometric and differential scanning calorimetry (DSC) techniques. By the analysis of fluorescence intensity, it was observed that Pd(II) complexes have strong abilities to quench the intrinsic fluorescence of HSA through a dynamic quenching procedure. The binding parameters were evaluated by the fluorescence quenching method. The thermodynamic parameters, including ΔH°, ΔS°, and ΔG°, were calculated by the fluorescence quenching method and indicated that hydrophobic forces play a major role in the interaction of Pd(II) complexes with HSA. Far-UV-CD results represented that Pd(II) complexes induced a decrease in content of the α helical structure of protein. The binding of newly designed drugs (Pd(II) complexes) on the blood carrier protein of HSA resulted in significant alterations on the structure and conformation of protein via decreasing stability of HSA by decreasing the Tm, a red shift in maximum fluorescence intensity, a decrease in content of the α-helical structure, and the increase of the nonpolar or accessible hydrophobic surface of HSA to solvent.Keywords
This publication has 33 references indexed in Scilit:
- Dendrimers Bind Human Serum AlbuminThe Journal of Physical Chemistry B, 2009
- 2,2′-Bipyridinebutyldithiocarbamatoplatinum(II) and palladium(II) complexes: Synthesis, characterization, cytotoxicity, and rich DNA-binding studiesBioorganic & Medicinal Chemistry, 2008
- The interaction of silibinin with human serum albumin: A spectroscopic investigationJournal of Photochemistry and Photobiology A: Chemistry, 2008
- Interaction of rofecoxib with human serum albumin: Determination of binding constants and the binding site by spectroscopic methodsJournal of Photochemistry and Photobiology A: Chemistry, 2008
- Studies of the interaction between palmatine hydrochloride and human serum albumin by fluorescence quenching methodJournal of Pharmaceutical and Biomedical Analysis, 2006
- Mixed complexes of Pt(II) and Pd(II) with ethylsarcosinedithiocarbamate and 2-/3-picoline as antitumor agentsJournal of Inorganic Biochemistry, 2005
- Structural Basis of the Drug-binding Specificity of Human Serum AlbuminJournal of Molecular Biology, 2005
- Toxic effects of bis(thiosemicarbazone) compounds and its palladium(II) complexes on herpes simplex virus growthToxicology and Applied Pharmacology, 2004
- Characterization of site I on human serum albumin: concept about the structure of a drug binding siteBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1996
- Complete amino acid sequence of human serum albuminFEBS Letters, 1975